Your browser doesn't support javascript.
loading
Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study.
Hochhaus, A; Masszi, T; Giles, F J; Radich, J P; Ross, D M; Gómez Casares, M T; Hellmann, A; Stentoft, J; Conneally, E; García-Gutiérrez, V; Gattermann, N; Wiktor-Jedrzejczak, W; le Coutre, P D; Martino, B; Saussele, S; Menssen, H D; Deng, W; Krunic, N; Bedoucha, V; Saglio, G.
Afiliação
  • Hochhaus A; Abteilung Hämatologie/Onkologie, Universitätsklinikum Jena, Jena, Germany.
  • Masszi T; Department of Haematology and Stem Cell Transplantation St István and St László Hospital, Budapest, Hungary.
  • Giles FJ; Developmental Therapeutics Program, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
  • Radich JP; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Ross DM; SA Pathology, Adelaide, SA, Australia.
  • Gómez Casares MT; Hospital Universitario Doctor Negrin, Las Palmas de Gran Canaria, Spain.
  • Hellmann A; Medical University of Gdansk, Gdansk, Poland.
  • Stentoft J; Aarhus University Hospital, Aarhus, Denmark.
  • Conneally E; St James Hospital, Dublin, Ireland.
  • García-Gutiérrez V; Servicio de Hematología, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain.
  • Gattermann N; Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
  • Wiktor-Jedrzejczak W; Medical University of Warsaw, Department of Hematology, Warsaw, Poland.
  • le Coutre PD; Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Martino B; Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy.
  • Saussele S; III. Med. Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany.
  • Menssen HD; Novartis Pharma AG, Basel, Switzerland.
  • Deng W; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Krunic N; Novartis Institute for Biomedical Research, Cambridge, MA, USA.
  • Bedoucha V; Novartis Pharma AG, Basel, Switzerland.
  • Saglio G; University of Turin, Orbassano, Italy.
Leukemia ; 31(7): 1525-1531, 2017 07.
Article em En | MEDLINE | ID: mdl-28218239
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article